S2 Ep15: Spotlighting New Standards in Lung Cancer in Salt Lake City
We recently traveled to Salt Lake City, Utah for a State of the Science Summit™ on Non–Small Cell Lung Cancer. At the meeting, faculty from the University of Utah and Intermountain Healthcare, delved into biomarker discoveries, research regarding the heredity of lung cancer, emerging treatment modalities, and practice-changing trials that have impacted the paradigm. Other topics included the ro...
40m Nov 07, 2019
40m
S2 Ep14: Howard "Skip" Burris, MD: A Passion for Befriending Patients and Always Being Kind
Howard A. Burris, MD, also known as Skip, of Sarah Cannon Research Institute, discussed how he wound up in the oncology space, his passion for getting to know and helping his patients, and some proud moments throughout his monumental career.
31m Nov 01, 2019
31m
S2 Ep13: Outlining Progress Made in Ovarian Cancer in Pittsburgh
We recently traveled to Pittsburgh, Pennsylvania for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from the University of Pittsburgh Medical Center highlighted the many advances made with PARP inhibitors, the importance of molecular testing, considerations for the frontline treatment of newly diagnosed disease, as well as the best options for neoadjuvant therapy. Fac...
34m Oct 24, 2019
34m
S2 Ep12: Talking Tumors: Adaptive Approaches in Triple-Negative and HR-Positive Breast Cancers
Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, shed light on treatment considerations for women with triple-negative breast cancer (TNBC) who are candidates for neoadjuvant therapy, emerging treatment strategies for patients with metastatic TNBC, as well as the optimal timing of genomic testing in women with progressive hormone receptor–positive disease.
40m Oct 16, 2019
40m
S2 Ep11: Spreading Newfound Treatment Strategies in Hematologic Malignancies in Seattle
We recently traveled to Seattle, California for a State of the Science Summit™ on Hematologic Malignancies. At the meeting, faculty from Seattle Cancer Care Alliance provided insight on current and evolving standards of care in leukemia, lymphoma, and myeloma, highlighting particular targets of interest for novel therapies.
32m Oct 09, 2019
32m
S2 Ep10: Examining Major Breakthroughs Made in Breast Cancer in Milwaukee
We recently traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer. At the meeting, faculty from Carbone Cancer Center of the University of Wisconsin highlighted the evolving paradigms across breast cancer subtypes and settings, such as early and advanced hormone receptor–positive breast cancer, early-stage HER2-positive breast cancer, and metastatic triple-negati...
25m Oct 02, 2019
25m
S2 Ep9: Perusing Progress Made in Ovarian Cancer Treatment Paradigm in Pasadena
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from City of Hope discussed the necessity of genetic testing as well as the latest data regarding the use of PARP inhibitors, immunotherapy, chemotherapy, and surgical debulking while explaining how these data can be interpreted in clinical practice.
29m Sep 23, 2019
29m
S2 Ep8: Maha Hussain, MD: Anything Is Possible With a Fire in the Belly
Maha Hussain, MD, FACP, FASCO, of Northwestern University Feinberg School of Medicine, reflected on the path that led her into genitourinary  cancers.
23m Sep 18, 2019
23m
S2 Ep7: Gaining Ground in GI Cancers in Denver
We recently traveled to Denver, Colorado, for a State of the Science Summit on Gastrointestinal Malignancies, which featured insights from University of Colorado and Rocky Mountain Cancer Centers faculty. Meeting topics spanned the importance of molecular testing in the management of newly diagnosed metastatic colorectal cancer, advances with biomarker-directed therapies and immunotherapies in ...
28m Sep 12, 2019
28m
S2 Ep6: Mapping Multiple Myeloma Advances in NYC
We recently traveled to New York City, New York, for a State of the Science Summit on Multiple Myeloma. We met with experts from Mount Sinai Hospital to gather updates on emerging treatment strategies in multiple myeloma, including headway made with CAR T-cell therapies, the role of genomics, the shift toward personalized medicine, and progress made with maintenance therapies.
31m Sep 04, 2019
31m
S2 Ep5: Garnering Breakthroughs in GU Cancers in Boston
We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Genitourinary Cancers. At the meeting, experts from Dana-Farber Cancer Institute discussed the latest updates in prostate cancer, including the role of radiation, the question of androgen deprivation therapy–associated cardiac complications, and novel imaging modalities being used in nonmetastatic hormone-sensi...
33m Aug 29, 2019
33m
S2 Ep4: Mastering New Advances in Hematologic Malignancies in Milwaukee
We recently traveled to Milwaukee, Wisconsin for a State of the Science Summit™ on Hematologic Malignancies. We met with experts from the Medical College of Wisconsin to gather updates in acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia, mantle cell lymphoma, and myeloproliferative neoplasms. Additionally, we heard the latest news surrounding chimeric antigen receptor T-ce...
24m Aug 20, 2019
24m
S2 Ep3: Talking Tumors: Leveraging Immunotherapy in Nonsquamous NSCLC
We recently traveled to Little Rock, Arkansas, for a State of the Science Summit™ on Non–Small Cell Lung Cancer. In advance of the meeting, we conducted a Twitter poll regarding the use of single-agent immunotherapy versus combination chemotherapy and immunotherapy in a patient with nonsquamous non–small cell lung cancer. During the meeting, we also asked our attendees to answer the poll to gau...
30m Aug 15, 2019
30m
S2 Ep2: Newfound Understandings of Neuroendocrine Treatment in Kentucky
We recently traveled to Lexington, Kentucky for a State of the Science Summit on Neuroendocrine Tumors. The meeting, led by experts from University of Kentucky Markey Cancer Center, spotlighted the latest management strategies in the treatment of patients with neuroendocrine tumors, starting with the diagnosis, classification, and staging of these tumors, to surgery and sequencing approaches wi...
27m Aug 07, 2019
27m
S2 Ep1: Perusing Breakthroughs in Breast Cancer in Pasadena
We recently traveled to Pasadena, California, for a State of the Science Summit on Breast Cancer. The meeting, which featured insight from experts from City of Hope, covered a wide array of topics, ranging from advances made in HER2-positive breast cancer, to key trials in metastatic triple-negative disease, to genomic assays used in hormone receptor–positive disease, to axilla management.
24m Jul 29, 2019
24m
S1 Ep50: Patrick I. Borgen, MD: From the Wild West of Breast Cancer Research to Chasing Cure
Patrick I. Borgen, MD, of Maimonides Medical Center, shares his live-by mottos as a breast cancer surgeon, a patient who defined his career, and what fuels his passion to fight breast cancer and remove opioid use after surgery.
33m Jul 24, 2019
33m
S1 Ep49: Navigating New Developments in NSCLC in Dallas
We recently traveled to Dallas, Texas for a State of the Science Summit on Non–Small Cell Lung Cancer. At the meeting, faculty from Baylor Scott and White Health System highlighted headway made in the treatment landscapes of non–small cell lung cancer according to histology, stage, and treatment intervention, the likes of which now include immunotherapy, targeted therapy, and chemotherapy.
22m Jul 20, 2019
22m
S1 Ep48: Tapping Into Great Progress Made in GI Cancers in Tampa
We recently traveled to Tampa, Florida, for a State of the Science Summit on Gastrointestinal Malignancies. At the meeting, faculty from Moffitt Cancer Center and Mayo Clinic reviewed the latest data in gastrointestinal oncology, covering all aspects of current care, from patient selection to the optimal timing of targeted therapy, immunotherapy, and chemotherapy, in neuroendocrine tumors, hepa...
27m Jul 14, 2019
27m
S1 Ep47: Hearing About Breakthroughs Made in Hematologic Malignancies in Boston
We recently traveled to Boston, Massachusetts, for a State of the Science Summit on Hematologic Malignancies, which featured insights from the faculty from Dana-Farber Cancer Institute. The meeting covered frontline approaches and sequencing challenges in multiple myeloma, key advances in mantle cell lymphoma, and novel agents in chronic lymphocytic leukemia. Experts also highlighted progress m...
21m Jun 25, 2019
21m
S1 Ep46: Discussing Pivotal Progress in Breast Cancer in Dallas
We recently traveled to Dallas, Texas, for a State of the Science Summit on Breast Cancer. During the meeting, faculty from Baylor Scott and White Health System and The University of Texas MD Anderson Cancer Center relayed the prognostic value of genomic assays in breast cancer and the scope of established and ensuing treatment approaches for those with early-stage and advanced disease.
17m Jun 18, 2019
17m
S1 Ep45: Contemplating Key Updates in GI Cancers in Charlotte
We recently traveled to Charlotte, North Carolina, for a State of the Science Summit™ on Gastrointestinal Cancers. During the meeting, the faculty shared expert insight on treatment approaches across metastatic colorectal cancer, locally advanced and metastatic pancreatic cancer, advanced hepatocellular carcinoma, neuroendocrine tumors, and advanced gastric cancer.
20m Jun 12, 2019
20m
S1 Ep44: Observing the Latest Developments in Ovarian Cancer in NYC
We recently traveled to New York City, New York, for a State of the Science SummitTM on Ovarian Cancer. During the meeting, the faculty shared their insight on the various surgical and medical treatment modalities in advanced ovarian cancer, as well as investigational interventions that may further define standards of care.
19m May 30, 2019
19m
S1 Ep43: Gaining Ground in GI Cancers in Durham
We recently traveled to Durham, North Carolina, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, we spoke with the faculty from Duke Health and UNC Health Care, who highlighted key updates from the 2019 Gastrointestinal Symposium.
25m May 23, 2019
25m
S1 Ep42: Examining Key Breast Cancer Updates in Chicago
We recently traveled to Chicago, Illinois, for a State of the Science Summit™ on Breast Cancer. During the meeting, the faculty provided a comprehensive look into present and potentially future standards of care in early-stage and advanced breast cancer subtypes.
14m May 15, 2019
14m
S1 Ep41: Getting Up to Speed On Key Developments in GI Cancers in Washington DC
We recently traveled to Washington D.C. for a State of the Science Summit on Gastrointestinal Malignancies. During the meeting, the faculty spoke to the clinically diverse and steadily expanding therapeutic armamentariums for patients with gastrointestinal malignancies.
16m May 08, 2019
16m
S1 Ep40: Highlighting Pivotal Data From 2018 ASH Annual Meeting
We recently traveled to Kansas City, Missouri, for a State of the Science Summit™ on Hematologic Malignancies. The meeting provided a comprehensive snapshot of the pivotal data that were presented at the 2018 ASH Annual Meeting, spanning several diseases, such as multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, and much more.
19m May 01, 2019
19m
S1 Ep39: Talking Tumors: MSK Faculty Highlight Ovarian Cancer Cases
We recently traveled to New York City for a State of the Science SummitTM on Ovarian Cancer and Soft Tissue Sarcoma. In keeping up with the constant and sometimes controversial landscape of ovarian cancer, we sat down with Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, to discuss two common clinical scenarios faced in practice, and ...
32m Apr 25, 2019
32m
S1 Ep38: Getting Educated On Advances Made With GI Cancers in Houston
Recently, we traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from the University of Texas MD Anderson Cancer Center and Baylor College of Medicine, discussed the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, and hepatocellular carcinoma.
23m Apr 18, 2019
23m
S1 Ep37: Highlighting Breakthroughs in Breast Cancer in Nashville
We recently ventured to Nashville, Tennessee for a State of the Science SummitTM on Breast Cancer. At this conference, we sat down with faculty from Sarah Cannon Research Institute, HCA Midwest Health, Virginia Cancer Specialists, and Memorial Sloan Kettering Cancer Center to discuss some of the practice-changing updates that have been occurring in the field.
21m Apr 10, 2019
21m
S1 Ep36: Spotlight on Clinical Scenarios in GEJ Cancer
We recently traveled to Pasadena, California for a State of the Science Summit™ on Gastrointestinal Malignancies. In keeping up with the rapidly changing landscape of gastroesophageal junction cancer, we sat down with Joseph Chao, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.
28m Apr 03, 2019
28m
S1 Ep35: Gaining Insight Into Progress Made With Genitourinary Cancers in Pasadena
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Genitourinary Malignancies. At the meeting, faculty from City of Hope, Huntsman Cancer Center, and the University of Washington discussed the rapidly evolving landscapes of kidney, bladder, and prostate cancer.
25m Mar 27, 2019
25m
S1 Ep34: Navigating New Advances in Breast Cancer in NYC
We recently traveled to New York City for a State of the Science Summit™ on Breast Cancer. During the meeting, faculty from the Icahn School of Medicine of Mount Sinai Health System, as well as Columbia University Medical Center, discussed the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breast cancer, hormone receptor-positive, HER2-negative ...
20m Mar 20, 2019
20m
S1 Ep33: Spotlight on Clinical Scenarios in Rectal Adenocarcinoma
We sat down with Marwan Fakih, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.
20m Mar 15, 2019
20m
S1 Ep32: Observing the Latest Advances in Ovarian Cancer in Boston
We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma. During the meeting, faculty from Dana-Farber Cancer Institute gave focused presentations on the facets of genetic testing in ovarian cancer, surgical options available for patients with newly diagnosed disease, and emerging strategies for the treatment of patients with ut...
22m Mar 06, 2019
22m
S1 Ep31: Learning More About Lung Cancer in Kansas City
We recently traveled to Kansas City, Missouri, for a State of the Science Summit™ on Advanced Non–Small Cell Lung Cancer. During the meeting, the faculty from St. Luke’s Cancer Institute and the University of Missouri-Kansas City gave focused presentations on recent progress made in squamous NSCLC and small cell lung cancer, provided tips on how to navigate the complex paradigm of oncogene-driv...
17m Feb 28, 2019
17m
S1 Ep30: Getting Up to Speed with Progress Made in GU Cancers in Memphis
We recently traveled to Memphis, Tennessee, for a State of the Science Summit™ on Genitourinary Cancers. During the meeting, the faculty gave focused presentations on advances made in the treatment landscapes of metastatic renal cell carcinoma and prostate cancer. In renal cell carcinoma, the faculty homed in on the role of adjuvant TKIs, the current and future use of immunotherapy, the utilit...
20m Feb 20, 2019
20m
S1 Ep29: Highlighting Headway Made in NSCLC in New York
We recently traveled to New York City for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The meeting, which featured insight from experts from NYU Langone’s Perlmutter Cancer Center, covered a wide array of topics, ranging from surgical techniques, to headway made in immunotherapy, to emerging biomarkers, to diagnostic advancements.
16m Feb 13, 2019
16m
S1 Ep28: Examining Breakthroughs Made in Breast Cancer in Minneapolis
We recently traveled to Minneapolis, Minnesota, for a State of the Science Summit on Breast Cancer. At the meeting, topics ranged from surgical approaches for node-positive breast cancer, to the use of CDK4/6 inhibitors in hormone receptor–positive disease, to emerging drug therapies in triple-negative disease. Presenters also highlighted treatment approaches for those with lymphedema, discusse...
18m Feb 06, 2019
18m
S1 Ep27: Navigating New Advances Made in NSCLC in New York
We recently traveled to Syracuse, New York, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, we spoke with the faculty of Upstate Medical University on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and minimally invasive surgery. They also discussed the im...
26m Jan 30, 2019
26m
S1 Ep26: Making Moves in Multiple Myeloma in NYC
We recently traveled to New York City for a State of the Science Summit on Multiple Myeloma. At the meeting, we spoke with the faculty of Mount Sinai to get their take on stem cell transplant, minimal residual disease, maintenance options, and treatment approaches for newly diagnosed myeloma. They also discussed outcomes for relapsed/refractory disease, novel agents in development, chimeric ant...
26m Jan 23, 2019
26m
S1 Ep25: Perusing Progress Made in NSCLC in Washington DC
Recently, we headed to Washington D.C. for a State of the Science Summit on Non–Small Cell Lung Cancer. Topics ranged from determining optimal strategies for molecular interrogation in NSCLC to the emergence of rare, targetable biomarkers—such as MET, RET, and NTRK. Presentations also focused on additional recent advances in the NSCLC and small cell lung cancer paradigms, touching on TKIs, immu...
21m Jan 16, 2019
21m
S1 Ep24: Talking Treatment Strategies for Breast Cancer in Pittsburgh
Recently, we visited Pittsburgh, Pennsylvania for a State of the Science Summit on Breast Cancer. Topics of discussion ranged from controversies in the management of hormone receptor-positive breast cancer to de-escalating therapy for patients with HER2-positive disease. Presentations also focused on novel approaches in metastatic triple-negative breast cancer and treatment strategies for patie...
22m Jan 09, 2019
22m
S1 Ep23: Snapshot of the 2018 ASH Annual Meeting in San Diego
In December 2018, we traveled to San Diego, California for the 2018 ASH Annual Meeting. At the conference, we spoke with several experts across hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.
18m Jan 04, 2019
18m
S1 Ep22: Buzzing With News From the San Antonio Breast Cancer Symposium
We visited San Antonio, Texas for the San Antonio Breast Cancer Symposium. At the meeting, physicians from all around the world presented studies in the field, several of which will have an immediate impact on practice. During our time there, we spoke to several principal investigators who detailed new applications of novel therapies, surgical intervention strategies, and lifestyle modifications.
22m Dec 22, 2018
22m
S1 Ep21: Exploring Strides Made in Ovarian Cancer & STS in Stanford
We visited Stanford, California for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma. The meeting covered advances made in the treatment landscapes, touching on available modalities, such as immunotherapy, antibody drug conjugates, and PARP inhibitors.
20m Dec 19, 2018
20m
S1 Ep20: Reflecting on New Advances Made in NSCLC in Chicago
On October 23, we traveled to Chicago, Illinois, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, faculty from Rush University Medical Center, the University of Chicago Medicine, the University of Illinois at Chicago, NorthShore University Health System, and Northwestern Feinberg School of Medicine reflected on updates in the field, particularly data fro...
21m Dec 05, 2018
21m
S1 Ep19: Gaining Insight Into Genitourinary Cancers in Charlotte
We visited Charlotte, North Carolina for a State of the Science Summit on Genitourinary Cancers. The meeting covered practice-changing clinical trials in nonmetastatic castration-resistant prostate cancer, treatment options for those with castration-sensitive prostate cancer, and the role of surgery in high-risk prostate cancer. Additionally, immunotherapy in advanced renal cell carcinoma was d...
24m Nov 28, 2018
24m
S1 Ep18: Keeping Up With Hematologic Advances in Clayton
We visited Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies with faculty from Washington University School of Medicine in St. Louis and Siteman Cancer Center. The meeting covered novel agents and combinations in chronic lymphocytic leukemia, advances in acute myeloid leukemia, management of newly diagnosed and relapsed/refractory multiple myeloma, progress in myel...
26m Nov 21, 2018
26m
S1 Ep17: Getting Educated With GI Cancer Therapies in Newport Beach
We flew to Newport Beach, California, for a State of the Science Summit on Gastrointestinal Cancers. The meeting focused on the evolving paradigms of colorectal cancer, pancreatic cancer, neuroendocrine tumors, gastric cancer, and hepatocellular carcinoma.
24m Nov 14, 2018
24m
S1 Ep16: Acquiring Lung Cancer Lessons in New Jersey
We visited Summit, New Jersey for a State of the Science Summit on non–small cell lung cancer. The meeting covered the current standard of care for early-stage lung cancer, approaches to locoregionally advanced NSCLC, updates in EGFR-positive NSCLC, emerging biomarkers, new data surrounding immunotherapy combinations, updates in squamous NSCLC, and advances in small cell lung cancer.
21m Nov 09, 2018
21m